Rosetta and Ingenuity Announce Collaboration
News Jan 26, 2006
Rosetta Biosoftware and Ingenuity Systems have announced a collaboration to establish interoperability between the Rosetta Resolver® system and the Ingenuity Pathways Analysis system.
Researchers will be able to exchange data between the two systems to leverage both systems' ability to analyze gene expression data and perform advanced pathway analysis.
"The Rosetta Resolver system is a comprehensive informatics solution for analyzing large amounts of data in preclinical and clinical studies or for research diagnostic purposes," said Yelena Shevelenko, vice president and general manager of Rosetta Biosoftware.
"We are pleased to provide seamless integration between Ingenuity's pathway analysis tools and the Rosetta Resolver system to our mutual customers, allowing them to uncover mechanisms of action, predict potential toxicities, and give biological meaning to their gene expression data."
"Connecting the Ingenuity Pathway Analysis solution with the Resolver system will increase the capabilities for our joint customers to derive increased understanding and insights from gene expression data," said Tuan Nguyen, VP, Partner and Professional Services of Ingenuity Systems.
"This collaboration represents an important step in our strategy to seamlessly integrate Ingenuity Pathways Analysis into the natural workflow of our customers."
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE